Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
73 hedge funds and large institutions have $119M invested in Akoya BioSciences in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 9 closing their positions.
138% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 13
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
16% more funds holding
Funds holding: 63 → 73 (+10)
9% more capital invested
Capital invested by funds: $109M → $119M (+$9.61M)
0.74% less ownership
Funds ownership: 34.84% → 34.1% (-0.74%)
24% less call options, than puts
Call options by funds: $176K | Put options by funds: $232K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
+$17.4M |
| 2 |
Millennium Management
New York
|
+$2.58M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$2.41M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.15M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HEC
Hudson Executive Capital
New York
|
-$14.2M |
| 2 |
ACM
Altium Capital Management
New York
|
-$4.09M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.95M |
| 4 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
-$1.2M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$767K |
AKYA Hedge Fund Activity: Q2 2023 in Review
73 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q2 2023, worth a combined $119M — up 8.8% from $109M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new AKYA positions and 9 closed out — a net gain of 10 holders — while 31 added to existing stakes and 13 trimmed.
The largest buyer was Blue Water Life Science Advisors, adding an estimated $17.4M. The largest seller was Hudson Executive Capital, exiting entirely with an estimated $14.2M sold.
- 73 institutional investors held Akoya BioSciences (AKYA) as of Q2 2023, up from 63 in Q1 2023.
- Funds reported $119M of Akoya BioSciences stock for Q2 2023, up 8.8% quarter-over-quarter.
- 19 funds opened new Akoya BioSciences positions in Q2 2023 and 9 closed out, a net change of +10 holders.
- The largest Akoya BioSciences buyer in Q2 2023 was Blue Water Life Science Advisors, an estimated $17.4M added.
- The largest Akoya BioSciences seller in Q2 2023 was Hudson Executive Capital, an estimated $14.2M sold.
Based on aggregated 13F filings for Q2 2023.